These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16235042)

  • 21. [PRESCRIPTION PATTERNS IN THE TREATMENT OF SCHIZOPHRENIA].
    Leiderman EA; Lorenzo L
    Vertex; 2015; 26(119):11-6. PubMed ID: 26323108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients' and psychiatrists' perceptions of clinical decisions during schizophrenia treatment.
    Hamann J; Mendel RT; Fink B; Pfeiffer H; Cohen R; Kissling W
    J Nerv Ment Dis; 2008 Apr; 196(4):329-32. PubMed ID: 18414128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physicians' and patients' involvement in relapse prevention with antipsychotics in schizophrenia.
    Hamann J; Mischo C; Langer B; Leucht S; Kissling W
    Psychiatr Serv; 2005 Nov; 56(11):1448-50. PubMed ID: 16282267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy.
    James BO; Omoaregba JO; Raji SO; Imishue OE; Okonoda KM; Nyamali YI; Famuyiwa PA; Correll CU
    Psychiatry Res; 2017 Feb; 248():134-139. PubMed ID: 28063386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychiatrists' decision making between branded and generic drugs.
    Hamann J; Mendel R; Kissling W; Leucht S
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):686-90. PubMed ID: 23021566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists.
    Newcomer JW; Nasrallah HA; Loebel AD
    J Clin Psychopharmacol; 2004 Oct; 24(5 Suppl 1):S1-6. PubMed ID: 15356414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsychotic use in patients with schizophrenia treated in private psychiatry.
    Simon AE; Peter M; Hess L; Valterio C
    Swiss Med Wkly; 2005 Feb; 135(7-8):109-15. PubMed ID: 15832227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns.
    Apiquian R; Fresán A; de la Fuente-Sandoval C; Ulloa RE; Nicolini H
    BMC Psychiatry; 2004 Apr; 4():12. PubMed ID: 15109398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychiatrists' use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topics.
    Hamann J; Mendel R; Cohen R; Heres S; Ziegler M; Bühner M; Kissling W
    Psychiatr Serv; 2009 Aug; 60(8):1107-12. PubMed ID: 19648199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychiatrists' attitudes about and informed consent practices for antipsychotics and tardive dyskinesia.
    Schachter DC; Kleinman I
    Psychiatr Serv; 2004 Jun; 55(6):714-7. PubMed ID: 15175474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which neuroleptic would psychiatrists take for themselves or their relatives?
    Steinert T
    Eur Psychiatry; 2003 Feb; 18(1):40-1. PubMed ID: 12648897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient, Physician and Organizational Influences on Variation in Antipsychotic Prescribing Behavior.
    Tang Y; Chang CC; Lave JR; Gellad WF; Huskamp HA; Donohue JM
    J Ment Health Policy Econ; 2016 Mar; 19(1):45-59. PubMed ID: 27084793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatrist and patient responses to suspected medication nonadherence in schizophrenia spectrum disorders.
    Hamann J; Lipp ML; Christ-Zapp S; Spellmann I; Kissling W
    Psychiatr Serv; 2014 Jul; 65(7):881-7. PubMed ID: 24686753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipsychotic prescribing: do conflict of interest policies make a difference?
    Anderson TS; Huskamp HA; Epstein AJ; Barry CL; Men A; Berndt ER; Horvitz-Lennon M; Normand SL; Donohue JM
    Med Care; 2015 Apr; 53(4):338-45. PubMed ID: 25769055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychiatrists' challenges in considering disclosure of schizophrenia diagnosis in Israel.
    Moran GS; Oz G; Karnieli-Miller O
    Qual Health Res; 2014 Oct; 24(10):1368-80. PubMed ID: 25147222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists.
    Hamann J; Pfeiffer H; Leucht S; Kissling W
    Pharmacopsychiatry; 2003 Nov; 36(6):309-12. PubMed ID: 14663656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Italian psychiatrists' perception on cognitive symptoms in major depressive disorder.
    Albert U; Brugnoli R; Caraci F; Dell'Osso B; Di Sciascio G; Tortorella A; Vampini C; Cataldo N; Pegoraro V
    Int J Psychiatry Clin Pract; 2016; 20(1):2-9. PubMed ID: 26523906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective.
    Altamura AC; Armadoros D; Jaeger M; Kernish R; Locklear J; Volz HP
    Curr Med Res Opin; 2008 Aug; 24(8):2271-82. PubMed ID: 18588748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sharing decisions in consultations involving anti-psychotic medication: a qualitative study of psychiatrists' experiences.
    Seale C; Chaplin R; Lelliott P; Quirk A
    Soc Sci Med; 2006 Jun; 62(11):2861-73. PubMed ID: 16343722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.